Cancer screening market is worth over $5 billion and growing at 7.0% CAGR, majority of the growth is in bowl cancer test kits, BD1 would be potentially a first mover on Ovarian and lung if successful.. How do you put a price on that ?
BD1 Price at posting:
2.3¢ Sentiment: None Disclosure: Held
